A few weeks ago, I expressed my frustrations at the endless cycle of the tobacco industry demanding more and more evidence to justify simple tobacco control measures – and governments around the world giving in. Yesterday, parts of the Trans-Pacific Partnership’s (TPP), a trade agreement currently being negotiated between 12 countries including the US, were […]
This post was written by Sam Byfield, a Senior Policy Advisor (LiveLighter) at the National Heart Foundation of Australia (Western Australia), and an Associate of the Nossal Institute for Global Health at the University of Melbourne. For questions regarding this post please contact firstname.lastname@example.org. On 27 February, the Framework Convention on Tobacco Control will celebrate […]
This week, we have seen yet another example of tobacco industry intimidation tactics being used to stop a government from enacting laws that will save lives and protect the public health. The Irish government announced that it is introducing plain packaging legislation, following through on its goal of becoming the first country in the European […]
We are delighted to present the Retrospective for the O’Neill Institute for National and Global Health Law at Georgetown University, Innovative Solutions for Complex Health Challenges: Our Past, Present, and Future.
Posted in FCTC, FDA, Global Health, Health reform, Healthcare, Human Rights, Resources, Tobacco, Trade, WHO ; Tagged: ACA, FCTC, food and drug law, global health law, Global Health Law LL.M., governance, health and human rights, HIV, national health law, oneillinstitute, public health law, retrospective, tobacco control, WHO.
The Commissioner of the United States Food and Drug Administration, Margaret Hamburg will provide the keynote address to the O’Neill Institute for National and Global Health Law’s Summer Program on Emerging Issues in Food and Drug Law. Margaret A. Hamburg became the 21st commissioner of food and drugs on May 18, 2009. The second woman […]
Please join the O’Neill Institute for National and Global Health Law at Georgetown University for a one-week intensive summer institute exploring the domestic and international legal, regulatory, and policy framework shaping the safety and availability of foods and medicines worldwide. The program will cover U.S. domestic law including recent laws and regulations; international regulatory harmonization […]
On February 11, 2014, the FDA launched “The Real Cost” education campaign, aimed at preventing at-risk youth from using tobacco and reducing the amount of teenagers who become regular smokers. In 2009, President Obama signed into law the Family Smoking Prevention and Tobacco Control Act, granting the FDA the authority to regulate tobacco. The campaign […]
Posted in FDA, Global Health, Health reform, Tobacco ; Tagged: Adolescent Health, anthropology, child health, children, HHS, National Healthcare, NCDs, non-communicable diseases, public health, Real Cost Campaign, Smoking, Teenagers, tobacco control.
This week, the second-largest drugstore chain CVS Caremark Corp. (CVS) announced that it will stop selling tobacco products in its 7,600 pharmacies starting on October 1. The medical and tobacco control advocacy organizations applaud the decision, as it contributes to combatting tobacco consumption in the U.S. and exerts pressure on competitors to do the same. […]
Posted in Health reform, Healthcare, Tobacco ; Tagged: ACA, access to health care, CVS, National Healthcare, Obamacare, pharmacies, president obama, retail clinics, retail health clinics, tobacco control.
The field of public health is premised on epidemiological number games. While eradicating disease may be the paragon of the field, in practice, public health leaders apply a more rational lens focused on achieving the best health outcomes for the majority. Tackling the health issues associated with tobacco products presents a ripe example of this […]
In her opening remarks to the 8th Global Conference on Health Promotion, Margaret Chan, Director General of the World Health Organization (WHO) warned: [e]fforts to prevent non-communicable diseases go against the business interests of powerful economic operators. In my view, this is one of the biggest challenges facing health promotion . . . [i]t is […]
Signup for our mailing list and stay up to date on the latest happenings at The O’Neill Institute
Or sign up for our RSS Feed
The views reflected in this blog are those of the individual authors and do not necessarily represent those of the O’Neill Institute for National and Global Health Law or Georgetown University. This blog is solely informational in nature, and not intended as a substitute for competent legal advice from a licensed and retained attorney in your state or country.